SEC FORM
3
SEC Form 3
FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL |
OMB Number: |
3235-0104 |
Estimated average burden |
hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person*
3000 SAND HILL ROAD |
BUILDING 1, SUITE 230 |
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 03/25/2008
|
3. Issuer Name and Ticker or Trading Symbol
CORCEPT THERAPEUTICS INC
[ CORT ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X |
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Form filed by One Reporting Person |
X |
Form filed by More than One Reporting Person |
|
Table I - Non-Derivative Securities Beneficially Owned |
1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Common Stock
|
3,530,450 |
D |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Warrants (right to buy)
|
|
03/24/2015 |
Common Stock |
1,765,225 |
2.77 |
D |
|
1. Name and Address of Reporting Person*
3000 SAND HILL ROAD |
BUILDING 1, SUITE 230 |
(Street)
|
1. Name and Address of Reporting Person*
3000 SAND HILL ROAD |
BUILDING 1, SUITE 230 |
(Street)
|
1. Name and Address of Reporting Person*
3000 SAND HILL ROAD |
BUILDING 1, SUITE 230 |
(Street)
|
1. Name and Address of Reporting Person*
3000 SAND HILL ROAD |
BUILDING 1, SUITE 230 |
(Street)
|
Explanation of Responses: |
|
/s/ Patrick G. Enright, Managing Member - For Longitude Capital Management, LLC, as general partner of Longitude Venture Partners, LP |
04/03/2008 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Exhibit 99.1
Form 3 Joint Filer Information
Name: Longitude Capital Management, LLC
Address: 3000 Sand Hill Road
Building 1, Suite 230
Menlo Park, CA 94025
Designated Filer: Longitude Venture Partners, L.P.
Issuer & Ticker Symbol: Corcept Therapeutics Incorporated (CORT)
Date of Event Requiring Statement: March 25, 2008
Signature: By: /s/ Patrick G. Enright
--------------------------------------
Name: Longitude Capital Associates, L.P.
Address: 3000 Sand Hill Road
Building 1, Suite 230
Menlo Park, CA 94025
Designated Filer: Longitude Venture Partners, L.P.
Issuer & Ticker Symbol: Corcept Therapeutics Incorporated (CORT)
Date of Event Requiring Statement: March 25, 2008
Signature: By: /s/ Patrick G. Enright
--------------------------------------
Name: Juliet Tammenoms Bakker
Address: 3000 Sand Hill Road
Building 1, Suite 230
Menlo Park, CA 94025
Designated Filer: Longitude Venture Partners, L.P.
Issuer & Ticker Symbol: Corcept Therapeutics Incorporated (CORT)
Date of Event Requiring Statement: March 25, 2008
Signature: By: /s/ Juliet Tammenoms Bakker
--------------------------------------